Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer
Clinical trial NCT06639724 · RECRUITING
Trial details
- NCT number
- NCT06639724
- Sponsor
- University of California, San Diego
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-05
- Primary completion
- 2027-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.